tiprankstipranks
Trending News
More News >
Silo Pharma (SILO)
NASDAQ:SILO
US Market

Silo Pharma (SILO) Income Statement

Compare
217 Followers

Silo Pharma Income Statement

Last quarter (Q3 2025), Silo Pharma's total revenue was $18.02K, a decrease of 0.00% from the same quarter last year. In Q3, Silo Pharma's net income was $-1.11M. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 72.10K$ 72.10K$ 72.10K$ 71.26K$ 0.00
Gross Profit
$ 66.26K$ 66.26K$ 66.26K$ 66.26K$ 0.00
Operating Expenses
$ 4.77M$ 3.92M$ 3.69M$ 2.81M$ 2.20M
Depreciation and Amortization
$ 6.18K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -4.38M$ -3.63M$ -3.91M$ 4.19M$ -2.40M
Operating Income
$ -4.71M$ -3.86M$ -3.63M$ -2.74M$ -2.20M
Other Income/Expenses
$ 312.81K$ 224.51K$ -279.73K$ 6.93M$ -464.55K
Pretax Income
$ -4.39M$ -3.63M$ -3.91M$ 4.18M$ -2.67M
Net Income
$ -4.39M$ -3.70M$ -3.91M$ 3.90M$ -3.04M
Per Share Metrics
Basic EPS
$ -1.19$ -1.20$ -1.71$ 1.32$ -2.35
Diluted EPS
$ -1.19$ -1.20$ -1.71$ 1.30$ -2.35
Weighted Average Shares Outstanding
3.68M 3.08M 2.28M 1.90M 1.32M
Weighted Average Shares Outstanding (Diluted)
3.68M 3.08M 2.28M 1.92M 1.32M
Currency in USD

Silo Pharma Earnings and Revenue History